Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05396963
Other study ID # EGGPROScience1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date September 30, 2023

Study information

Verified date October 2023
Source Aristotle University Of Thessaloniki
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Research has shown positive effects of HIFT on body composition, cardiorespiratory fitness, and muscle performance of young individuals. The effectiveness of HIFT in higher ages and its protein requirements are less well documented. Protein requirements have been widely investigated in resistance training, where it has been found that protein supplementation may have additive beneficial effects on muscle strength and lean body mass. However, there is a research gap regarding the adaptations to HIFT when combined with protein supplementation. Thus, the aim of this research is to compare the effects of egg white supplementation, whey protein supplementation (as a positive comparator), and maltodextrin (a carbohydrate as placebo) on body composition, physical performance, and plasma amino acid profile in young and middle-aged trained individuals of both sexes who perform HIFT. Participants will take all three supplements for 6 weeks each, with 2 weeks of washout (no supplementation) in between, in random and counterbalanced order. Researchers will not know the supplementation status of the participants. Participants will receive 0.6 g of protein or placebo per kg body weight daily on top of isoenergetic dietary plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. The HIFT protocol will include multimodal patterns of movement, combining endurance and strengthening exercises with the use of equipment such as Total Resistance eXercise (TRX), Bosu, kettlebells, and barbells. Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition at the beginning and end of the study, as well as during the two washout periods. Also, plasma amino acids, hematology, biochemistry, and hormones will be measured. Comparison of all these outcome measures between supplements will reveal whether protein supplementation is useful in HIFT.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 30, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Regular training (mixed endurance and resistance training 3 to 6 times a week, 50 min each session, for the past 4 months), as assessed by gym records or questionnaires - Clearance from a pathologist or cardiologist to perform maximal exercise - Mixed isoenergetic diet for the past 4 months Exclusion Criteria: - Smoking (even one cigarette or nicotine-containing device over the past 6 months) - Any injuries to the musculoskeletal system that could interfere with the execution of training - Chronic disease - Egg allergy - Milk allergy - Pregnancy, lactation, or planning a pregnancy within the duration of the study - Regular use of prescription medicine or supplements that might affect muscle function or recovery over the past month - Intermittent or religious fasting - Any vegetarian, ketogenic or protein diet

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Egg white
Intake of egg white
Whey protein
Intake of whey protein
Maltodextrin
Intake of maltodextrin

Locations

Country Name City State
Greece Laboratory of Evaluation of Human Biological Performance Thessaloniki

Sponsors (3)

Lead Sponsor Collaborator
Aristotle University Of Thessaloniki European Commission, Greek Ministry of Development

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lean and fat mass pre-supplementation Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry. Within 2 weeks before the beginning of supplementation.
Primary Lean and fat mass post-supplementation Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry. Within 2 weeks after the end of supplementation.
Primary Maximal dynamic strength of shoulder muscles pre-supplementation Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum. Within 2 weeks before the beginning of supplementation.
Primary Maximal dynamic strength of shoulder muscles post-supplementation Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum. Within 2 weeks after the end of supplementation.
Primary Force-velocity relationship of knee flexors and extensors pre-supplementation Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer. Within 2 weeks before the beginning of supplementation.
Primary Force-velocity relationship of knee flexors and extensors post-supplementation Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer. Within 2 weeks after the end of supplementation.
Primary Plasma amino acid profile pre-supplementation Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry. Within 4 days before the beginning of supplementation.
Primary Plasma amino acid profile post-supplementation Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry. Within 4 days after the end of supplementation.
Primary Aerobic fitness pre-supplementation Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill. Within 2 weeks before the beginning of supplementation.
Primary Aerobic fitness post-supplementation Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill. Within 2 weeks after the end of supplementation.
Primary Muscle endurance pre-supplementation Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions. Within 2 weeks before the beginning of supplementation.
Primary Muscle endurance post-supplementation Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions. Within 2 weeks after the end of supplementation.
Secondary Biochemical analyses pre-supplementation Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer. Within 4 days before the beginning of supplementation.
Secondary Biochemical analyses post-supplementation Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer. Within 4 days after the end of supplementation.
Secondary Hormonal analyses pre-supplementation Plasma cortisol and testosterone (both in µg/dL) will be measured by immunoluminescence in an automated analyzer. Within 4 days before the end of supplementation.
Secondary Hormonal analyses post-supplementation Plasma cortisol and testosterone (both in µg/dL) will be measured by immunoluminescence in an automated analyzer. Within 4 days after the end of supplementation.
Secondary Resting metabolic rate pre-supplementation Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer. Within 2 weeks before the beginning of supplementation.
Secondary Resting metabolic rate post-supplementation Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer. Within 2 weeks after the end of supplementation.
Secondary Internal load of exercise pre-supplementation Internal load of exercise will be assessed by telemetric heart rate sensors and software Within the first week of supplementation.
Secondary Internal load of exercise post-supplementation Internal load of exercise will be assessed by telemetric heart rate sensors and software Within the last week of supplementation (week 6).
Secondary Full blood count pre-supplementation Full blood count will be performed by flow cytometry Within 4 days before the beginning of supplementation
Secondary Full blood count post-supplementation Full blood count will be performed by flow cytometry Within 4 days after the end of supplementation.
Secondary Plasma enzymes pre-supplementation Creatine kinase and ?-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer Within 4 days before the beginning of supplementation.
Secondary Plasma enzymes post-supplementation Creatine kinase and ?-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer. Within 4 days after the end of supplementation.
Secondary Force-velocity relationship of shoulder muscles pre-supplementation Force-velocity relationship of shoulder muscles will be assessed by a linear encoder. Within 2 weeks before the beginning of supplementation.
Secondary Force-velocity relationship of shoulder muscles post-supplementation Force-velocity relationship of shoulder muscles will be assessed by a linear encoder. Within 2 weeks after the end of supplementation.
Secondary Maximal grip strength pre-supplementation Maximal grip strength will be assessed by a hand dynamometer Within 2 weeks before the beginning of supplementation
Secondary Maximal grip strength post-supplementation Maximal grip strength will be assessed by a hand dynamometer Within 2 weeks after the end of supplementation.
See also
  Status Clinical Trial Phase
Completed NCT05820399 - Guayusa Extract on Exercise Training N/A
Active, not recruiting NCT04295590 - Impact of Augmenting Exercise Intensity vs. Frequency N/A
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Completed NCT03563430 - Effects of Different Recovery Methods on Lactic Acid Removal, Flexibility, Strength, and Endurance N/A
Completed NCT02981667 - Higher Enjoyment in Response to High Intensity Interval Training Versus Moderate Intensity Continuous Exercise N/A
Completed NCT05255497 - The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy N/A
Completed NCT04084535 - Effects of High Intensity Interval Training (HIIT) vs. Inspiratory Muscle Training on the Recovery After a Maximal Apnea. N/A
Completed NCT04384185 - Combined Treatment of Manual Therapy and Therapeutic Exercise in Patients With Low Back Pain N/A
Completed NCT04114175 - Spinal Stabilization Exercises in Individuals With Transtibial Amputatıon N/A
Completed NCT02958657 - Effect of Exercise on Platelet Reactivity After Myocardial Infarction N/A
Not yet recruiting NCT00808600 - Empowerment of Lung and Heart-lung Transplant Patients N/A
Completed NCT04450134 - Histamine H1/H2 Receptors and Training Adaptations N/A
Completed NCT02999139 - Analytic, Prospective Cohort Study of Athletes Enrolled in an Exercise Training Intervention
Not yet recruiting NCT04366414 - Breathing Protocol in Breath-hold Divers N/A
Recruiting NCT04311736 - Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults N/A
Recruiting NCT03754478 - Follow-Up of Fitness in Overweight Patients Treated With Physical Activity
Completed NCT05402527 - Fish Nutrient Supplementation in High-intensity Functional Training N/A
Completed NCT06138951 - Exercise Dose-response and Protein Requirements N/A
Recruiting NCT06260579 - Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity N/A
Recruiting NCT04936737 - The Influence of Exercise on Tissue Beta-alanine Uptake and Carnosine Synthesis Rates N/A